(5-aminothiophen-2-yl)(pyrrolidin-1-yl)methanone | 1404113-01-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻吩类
• 英文名称: (5-aminothiophen-2-yl)(pyrrolidin-1-yl)methanone
• 英文别名: (5-Aminothiophen-2-yl)-pyrrolidin-1-ylmethanone；(5-aminothiophen-2-yl)-pyrrolidin-1-ylmethanone
• CAS: 1404113-01-4
• 化学式: C₉H₁₂N₂OS
• 分子量: 196.273
• InChiKey: YIQPIYXUNUQIQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  74.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (5-aminothiophen-2-yl)(pyrrolidin-1-yl)methanone 在 lithium aluminium tetrahydride 、 苯酚 作用下， 以 四氢呋喃 为溶剂， 反应 5.5h， 生成 7-chloro-N-[5-(pyrrolidin-1-ylmethyl)-2-thienyl]quinolin-4-amine
  参考文献：
  名称：

  Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline

  摘要：

  With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4-aminoquinoline was synthesized and tested in vitro against D-10 (CQ-S) and W-2 (CQ-R) strains of Plasmodium falciparum. All compounds exhibited from moderate to high antiplasmodial activities. The activity was strongly influenced both by the presence of a methylenic group, as a spacer between the 4-aminoquinoline and the heterocyclic ring, and by the presence of a basic head. The most potent molecules inhibited the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 < 30 nM and were not toxic against human endothelial cells. These results confirm that the presence of an heteroaryl moiety in the side chain of 7-chloro-4-aminoquinoline is useful for the design and development of new powerful antimalarial agents. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.07.040
• 作为产物：
  描述：

  5-硝基噻吩-2-甲酸 在 氯化亚砜 、 三乙醇胺 、 铁粉 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 反应 0.75h， 生成 (5-aminothiophen-2-yl)(pyrrolidin-1-yl)methanone
  参考文献：
  名称：

  Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline

  摘要：

  With the aim to investigate the effect of different heterocyclic rings linked to the 4-aminoquinoline nucleus on the antimalarial activity, a set of 7-chloro-N-(heteroaryl)-methyl-4-aminoquinoline and 7-chloro-N-(heteroaryl)-4-aminoquinoline was synthesized and tested in vitro against D-10 (CQ-S) and W-2 (CQ-R) strains of Plasmodium falciparum. All compounds exhibited from moderate to high antiplasmodial activities. The activity was strongly influenced both by the presence of a methylenic group, as a spacer between the 4-aminoquinoline and the heterocyclic ring, and by the presence of a basic head. The most potent molecules inhibited the growth of both CQ-S and CQ-R strains of P. falciparum with IC50 < 30 nM and were not toxic against human endothelial cells. These results confirm that the presence of an heteroaryl moiety in the side chain of 7-chloro-4-aminoquinoline is useful for the design and development of new powerful antimalarial agents. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2012.07.040

文献信息

• GAS41 INHIBITORS AND METHODS OF USE THEREOF
  申请人：The Regents of the University of Michigan

  公开号：US20220017509A1

  公开（公告）日：2022-01-20

  Provided herein are small molecules that bind to GAS41 and inhibit GAS41 activity, and methods of use thereof for the treatment of cancer.

  本文提供了结合到GAS41并抑制GAS41活性的小分子，以及将其用于治疗癌症的方法。
• Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer
  作者：Chenfan Li、Xiaoli Han、Qiuxia Yan、Yang Ji、Rongyu Zhang、Dazhong Yuan、Fulian Yang、Jianlong Wang、Meng Wu、Jinming Zhou

  DOI：10.1021/acs.jmedchem.3c01668

  日期：2024.3.14

  Androgen receptor (AR) antagonists play important roles in the treatment of castration-resistant prostate cancer (CRPC). The glucocorticoid receptor (GR) upregulation leads to drug resistance for clinically used antiandrogens. Therefore, blocking AR/GR signaling simultaneously has become an efficient strategy to overcome the drug resistance of CRPC. Our previous work indicated that Z19 could inhibit

  雄激素受体（AR）拮抗剂在去势抵抗性前列腺癌（CRPC）的治疗中发挥着重要作用。糖皮质激素受体（GR）上调会导致临床使用的抗雄激素产生耐药性。因此，同时阻断AR/GR信号已成为克服CRPC耐药性的有效策略。我们之前的工作表明Z19可以抑制AR和GR的活性。在此，我们优化了Z19的结构，并将GA32鉴定为有效的 AR/GR 双重抑制剂。 GA32有效降低 AR/GR 下游基因的 mRNA 和蛋白质水平。 GA32在体外和体内均能有效抑制恩杂鲁胺耐药性 CRPC 的增殖。 GA32可以直接与AR和GR结合，并且预测的GA32与AR/GR的结合模式表明GA32与AR或GR激素结合口袋结合。这项工作提供了一种具有双重 AR/GR 抑制活性的潜在先导化合物，以克服 CRPC 的耐药性。